These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24153205)

  • 1. 4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: urea-based analogs.
    Yang SM; Tang Y; Zhang R; Lu H; Kuo GH; Gaul MD; Li Y; Ho G; Conway JG; Liang Y; Lenhard JM; Demarest KT; Murray WV
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6773-6. PubMed ID: 24153205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: part 2. Pyridazine-based analogs.
    Yang SM; Tang Y; Rano T; Lu H; Kuo GH; Gaul MD; Li Y; Ho G; Lang W; Conway JG; Liang Y; Lenhard JM; Demarest KT; Murray WV
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1437-41. PubMed ID: 24405703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors.
    Xin Z; Zhao H; Serby MD; Liu B; Liu M; Szczepankiewicz BG; Nelson LT; Smith HT; Suhar TS; Janis RS; Cao N; Camp HS; Collins CA; Sham HL; Surowy TK; Liu G
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4298-302. PubMed ID: 18632269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel SCD1 inhibitors: 5-alkyl-4,5-dihydro-3H-spiro[1,5-benzoxazepine-2,4'-piperidine] analogs.
    Uto Y; Ueno Y; Kiyotsuka Y; Miyazawa Y; Kurata H; Ogata T; Takagi T; Wakimoto S; Ohsumi J
    Eur J Med Chem; 2011 May; 46(5):1892-6. PubMed ID: 21356569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Novel and Potent Stearoyl Coenzyme A Desaturase 1 (SCD1) Inhibitors as Anticancer Agents.
    Imamura K; Tomita N; Kawakita Y; Ito Y; Ono K; Nii N; Miyazaki T; Yonemori K; Tawada M; Sumi H; Satoh Y; Yamamoto Y; Miyahisa I; Sasaki M; Satomi Y; Hirayama M; Nishigaki R; Maezaki H
    Bioorg Med Chem; 2017 Jul; 25(14):3768-3779. PubMed ID: 28571972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzimidazole-carboxamides as potent and bioavailable stearoyl-CoA desaturase (SCD1) inhibitors from ligand-based virtual screening and chemical optimization.
    Matter H; Zoller G; Herling AW; Sanchez-Arias JA; Philippo C; Namane C; Kohlmann M; Pfenninger A; Voss MD
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1817-22. PubMed ID: 23395660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of novel stearoyl-CoA desaturase 1 inhibitors: 1'-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-3,4-dihydrospiro[chromene-2,4'-piperidine] analogs.
    Uto Y; Ueno Y; Kiyotsuka Y; Miyazawa Y; Kurata H; Ogata T; Yamada M; Deguchi T; Konishi M; Takagi T; Wakimoto S; Ohsumi J
    Eur J Med Chem; 2010 Nov; 45(11):4788-96. PubMed ID: 20801551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of piperazin-1-ylpyridazine-based potent and selective stearoyl-CoA desaturase-1 inhibitors for the treatment of obesity and metabolic syndrome.
    Zhang Z; Sun S; Kodumuru V; Hou D; Liu S; Chakka N; Sviridov S; Chowdhury S; McLaren DG; Ratkay LG; Khakh K; Cheng X; Gschwend HW; Kamboj R; Fu J; Winther MD
    J Med Chem; 2013 Jan; 56(2):568-83. PubMed ID: 23245208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel spiropiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 1'-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-5-(trifluoromethyl)-3,4-dihydrospiro[chromene-2,4'-piperidine].
    Uto Y; Kiyotsuka Y; Ueno Y; Miyazawa Y; Kurata H; Ogata T; Deguchi T; Yamada M; Watanabe N; Konishi M; Kurikawa N; Takagi T; Wakimoto S; Kono K; Ohsumi J
    Bioorg Med Chem Lett; 2010 Jan; 20(2):746-54. PubMed ID: 20006498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bicyclic heteroaryl inhibitors of stearoyl-CoA desaturase: from systemic to liver-targeting inhibitors.
    Ramtohul YK; Powell D; Leclerc JP; Leger S; Oballa R; Black C; Isabel E; Li CS; Crane S; Robichaud J; Guay J; Guiral S; Zhang L; Huang Z
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5692-6. PubMed ID: 21871798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAR and optimization of thiazole analogs as potent stearoyl-CoA desaturase inhibitors.
    Ramtohul YK; Black C; Chan CC; Crane S; Guay J; Guiral S; Huang Z; Oballa R; Xu LJ; Zhang L; Li CS
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1593-7. PubMed ID: 20137926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of 1-(4-phenoxypiperidin-1-yl)-2-arylaminoethanone stearoyl-CoA desaturase 1 inhibitors.
    Zhao H; Serby MD; Smith HT; Cao N; Suhar TS; Surowy TK; Camp HS; Collins CA; Sham HL; Liu G
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3388-91. PubMed ID: 17434733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438).
    Léger S; Black WC; Deschenes D; Dolman S; Falgueyret JP; Gagnon M; Guiral S; Huang Z; Guay J; Leblanc Y; Li CS; Massé F; Oballa R; Zhang L
    Bioorg Med Chem Lett; 2010 Jan; 20(2):499-502. PubMed ID: 20004097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of liver-targeted inhibitors of stearoyl-CoA desaturase (SCD1).
    Deng Y; Yang Z; Shipps GW; Lo SM; West R; Hwa J; Zheng S; Farley C; Lachowicz J; van Heek M; Bass AS; Sinha DP; Mahon CR; Cartwright ME
    Bioorg Med Chem Lett; 2013 Feb; 23(3):791-6. PubMed ID: 23265904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazole analog as stearoyl-CoA desaturase 1 inhibitor.
    Li CS; Belair L; Guay J; Murgasva R; Sturkenboom W; Ramtohul YK; Zhang L; Huang Z
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5214-7. PubMed ID: 19632834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic evaluation of amide bioisosteres leading to the discovery of novel and potent thiazolylimidazolidinone inhibitors of SCD1 for the treatment of metabolic diseases.
    Sun S; Zhang Z; Kodumuru V; Pokrovskaia N; Fonarev J; Jia Q; Leung PY; Tran J; Ratkay LG; McLaren DG; Radomski C; Chowdhury S; Fu J; Hubbard B; Winther MD; Dales NA
    Bioorg Med Chem Lett; 2014 Jan; 24(2):520-5. PubMed ID: 24374272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of triazolone derivatives as novel, potent stearoyl-CoA desaturase-1 (SCD1) inhibitors.
    Sun S; Zhang Z; Pokrovskaia N; Chowdhury S; Jia Q; Chang E; Khakh K; Kwan R; McLaren DG; Radomski CC; Ratkay LG; Fu J; Dales NA; Winther MD
    Bioorg Med Chem; 2015 Feb; 23(3):455-65. PubMed ID: 25555732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stearoyl-CoA desaturase as a new drug target for obesity treatment.
    Dobrzyn A; Ntambi JM
    Obes Rev; 2005 May; 6(2):169-74. PubMed ID: 15836467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part I: Discovery of 3-(2-hydroxyethoxy)-4-methoxy-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide.
    Uto Y; Ogata T; Harada J; Kiyotsuka Y; Ueno Y; Miyazawa Y; Kurata H; Deguchi T; Watanabe N; Takagi T; Wakimoto S; Okuyama R; Abe M; Kurikawa N; Kawamura S; Yamato M; Osumi J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4151-8. PubMed ID: 19540759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of potent liver-selective stearoyl-CoA desaturase-1 (SCD1) inhibitors, thiazole-4-acetic acid derivatives, for the treatment of diabetes, hepatic steatosis, and obesity.
    Iida T; Ubukata M; Mitani I; Nakagawa Y; Maeda K; Imai H; Ogoshi Y; Hotta T; Sakata S; Sano R; Morinaga H; Negoro T; Oshida S; Tanaka M; Inaba T
    Eur J Med Chem; 2018 Oct; 158():832-852. PubMed ID: 30248655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.